Series date: 
01/01/2022 - 12:30pm to 12/31/2022 - 1:30pm

DESCRIPTION
Cancer Center Grand Rounds occurs on the 1st, 3rd, and 5th Fridays of each month, where learners discuss various cases, updates, new technologies and treatments. This series is geared to physicians, residents/fellows, and mid-level providers.

TARGET AUDIENCE
This course is intended primarily for physicians, residents/fellows, NPs, PAs working in Hem/Onc.

LEARNING OBJECTIVES
Upon completion of this activity, participants should be able to:

  • Define patients who are candidates for intensive therapies and clinical trials.
  • Identify new therapies and available clinical trials.


Accreditation Statement
In support of improving patient care, Mayo Clinic College of Medicine and Science is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.



Credit Statement(s): 
AMA
Mayo Clinic College of Medicine and Science designates this live activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 

AAPA
Mayo Clinic College of Medicine and Science has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.00 AAPA Category 1 CME credits. PAs should only claim credit commensurate with the extent of their participation.

(AAPA credit added as of 6/16/2022)

 


ANCC
Mayo Clinic College of Medicine and Science designates this activity for a maximum of 1.00 ANCC contact hours. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

(ANCC added as of 6/16/2022)


DISCLOSURE SUMMARY
As a provider accredited by Joint Accreditation for Interprofessional Continuing Education, Mayo Clinic College of Medicine and Science must ensure balance, independence, objectivity and scientific rigor in its educational activities.  All who are in a position to control the content are required to disclose all financial relationships with any ineligible company.   Faculty will also identify any off-label and/or investigational use of pharmaceuticals or instruments discussed in their content for FDA compliance.
 
Listed below are individuals with control of the content of this program who have disclosed…
 
Relevant financial relationship(s) with ineligible companies:
James Foran M.D. – Consultant - Amgen, BMS, Novartis, Pfizer, Sanofi, Servier, Taiho; Grant/Research Support - AbbVie, Actinium, Aptose, Astex, H3Biosciences, Kura Oncology, Sellas, Stemline Therapeutics, Trillium, Xencor.

Rami Manochakian, MD- Consultant - Advisory Boards: Janssen and Turning Points

All relevant financial relationships have been mitigated. 
 
No relevant financial relationship(s) with ineligible companies:
Dawnishia Greenwade; Haley Baxter; Patience Durbin; Kimmie Holcomb; Tiawan Fagan; Amber Joice; Ashton Boyle, PA-C (added June 16, 2022); Victoria Alegria, APRN (added June 16, 2022)


For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

 

ATTENDANCE/CREDIT
Text the session code (provided only at the session) to 507-200-3010 within 48 hours of the live presentation to record attendance.  All learners are encouraged to text attendance regardless of credit needs.  This number is only used for receiving text messages related to tracking attendance.  Additional tasks to obtain credit may be required based on the specific activity requirements and will be announced accordingly. Swiping your badge will not provide credit; that process is only applicable to meet GME requirements for Residents & Fellows.


COURSE DIRECTORS 
James Foran, MD & Rami Manochakian, MD


QUESTIONS?
Contact Haley Baxter or Patience Durbin

Where did the idea for the course originate?: 
Florida

Sessions

Session Date
The Evolution and Contemporary Management of the Axilla in Breast Cancer 6.10.2022 06/10/2022 - 12:30pm to 1:30pm
Proton Therapy for Locally Advance Breast Cancer with a Focus on Cardiac Benefits 7.18.2022 07/18/2022 - 12:30pm to 1:30pm
2030 and Beyond: Building the Mayo Clinic in Florida Cancer center of the Future 8.19.2022 08/19/2022 - 12:30pm to 1:30pm
Global Health Equity: The Journey and the Vision 9.2.2022 09/02/2022 - 12:30pm to 1:30pm
Individualized Treatment Strategies for Metastatic Prostate Cancer 10.14.22 10/14/2022 - 12:30pm to 1:30pm
The Pandemic Burnout: Proven Insider Tips to Go the Distance 11.11.2022 11/11/2022 - 12:30pm to 1:30pm
Oncologic Anthropology: Triple Negative Breast Cancer & African Ancestry 12.09.22 12/09/2022 - 12:30pm to 1:30pm

Pages